Back
Aclaris Therapeutics, Inc. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Buy
55
ACRS
Aclaris Therapeutics, Inc.
Last Price:
$3.48
Seasonality Move:
26.08%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
The current trend is moderately bullish and ACRS is experiencing selling pressure, which indicates risk of future bearish movement.
Aclaris Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.96 | Sell |
| 20-day SMA: | 3.24 | Buy |
| 50-day SMA: | 3.01 | Buy |
| 200-day SMA: | 2.01 | Buy |
| 8-day EMA: | 3.76 | Sell |
| 20-day EMA: | 3.44 | Buy |
| 50-day EMA: | 3.05 | Buy |
| 200-day EMA: | 2.35 | Buy |
Aclaris Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 53.49 | Buy |
| Chaikin Money Flow: | -1533626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.55 - 3.85) | Buy |
| Bollinger Bands (100): | (1.91 - 3.17) | Buy |
Aclaris Therapeutics, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics, Inc. Stock
Is Aclaris Therapeutics, Inc. Stock a Buy?
-
Aclaris Therapeutics, Inc. share price is 3.51 while ACRS 8-day simple moving average is 3.96, which is a Sell signal.
-
The stock price of ACRS is 3.51 while Aclaris Therapeutics, Inc. 20-day SMA is 3.24, which makes it a Buy.
-
Aclaris Therapeutics, Inc. 50-day simple moving average is 3.01 while ACRS share price is 3.51, making it a Buy technically.
-
ACRS stock price is 3.51 and Aclaris Therapeutics, Inc. 200-day simple moving average is 2.01, creating a Buy signal.
ACRS Technical Analysis vs Fundamental Analysis
Buy
55
Aclaris Therapeutics, Inc. (ACRS)
is a Buy
Is Aclaris Therapeutics, Inc. a Buy or a Sell?
-
Aclaris Therapeutics, Inc. stock is rated a BuyThe current Aclaris Therapeutics, Inc. [ACRS] share price is $3.51. The Score for ACRS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Aclaris Therapeutics, Inc. Stock Info
Market Cap:
377M
Price in USD:
3.51
Share Volume:
1.6M
Aclaris Therapeutics, Inc. 52-Week Range
52-Week High:
4.89
52-Week Low:
1.05
Buy
55
Aclaris Therapeutics, Inc. (ACRS)
is a Buy
Aclaris Therapeutics, Inc. Share Price Forecast
-
What is the Aclaris Therapeutics, Inc. stock price today?The Aclaris Therapeutics, Inc. stock price is 3.51 USD today.
-
Will ACRS stock go up or go down?Aclaris Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aclaris Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics, Inc. is not overvalued.
Is Aclaris Therapeutics, Inc. Stock a Buy?
-
Aclaris Therapeutics, Inc. share price is 3.51 while ACRS 8-day exponential moving average is 3.76, which is a Sell signal.
-
The stock price of ACRS is 3.51 while Aclaris Therapeutics, Inc. 20-day EMA is 3.44, which makes it a Buy.
-
Aclaris Therapeutics, Inc. 50-day exponential moving average is 3.05 while ACRS share price is 3.51, making it a Buy technically.
-
ACRS stock price is 3.51 and Aclaris Therapeutics, Inc. 200-day simple moving average is 2.35, creating a Buy signal.
Fundamental Analysis of Aclaris Therapeutics, Inc.
Is Aclaris Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Aclaris Therapeutics, Inc.
Should I short Aclaris Therapeutics, Inc. stock?
-
ACRS Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Aclaris Therapeutics, Inc. is a Buy
-
Aclaris Therapeutics, Inc. Relative Strength Index (RSI) is 53.49, which suggest Aclaris Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Aclaris Therapeutics, Inc. is (2.55 - 3.85), which suggest Aclaris Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Aclaris Therapeutics, Inc. is (1.91 - 3.17), which suggest Aclaris Therapeutics, Inc. is a Buy
* Aclaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.